# Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)

> **NCT01884350** · PHASE4 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 1217 (actual)

## Conditions studied

- Non-valvular Atrial Fibrillation

## Interventions

- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT01884350
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10-15
- **Primary completion:** 2016-01-20
- **Final completion:** 2016-01-20
- **Target enrollment:** 1217 (ACTUAL)
- **Last updated:** 2019-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01884350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01884350, "Assessment of an Education and Guidance Programme for Eliquis Adherence in Non-Valvular Atrial Fibrillation (AEGEAN)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01884350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*